16
Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Monitoring in Cambodia 1997 - 2003

Embed Size (px)

Citation preview

Page 1: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Monitoring

in Cambodia 1997 - 2003

Page 2: Drug Resistance Monitoring in Cambodia 1997 - 2003

Sensitivity (S or S/RI) at 4 Sensitivity (S or S/RI) at 4 sentinel sites 1991 – 97sentinel sites 1991 – 97

Western areas: Western areas: Battambang, Pursat, Battambang, Pursat, Eastern areas:Eastern areas: Ratanakiri, KratieRatanakiri, Kratie

Chloroquine Chloroquine --1991-93 (West): 1991-93 (West): S or S/RI = 3-12% S or S/RI = 3-12% -1997 (East): -1997 (East): S/RI = 76%-86%S/RI = 76%-86%

Fansidar® Fansidar® -1991-95 (West): -1991-95 (West): S or S/RI = 0-13%S or S/RI = 0-13%-1991-95 (East): -1991-95 (East): S or S/RI = 57-80%S or S/RI = 57-80%

Quinine and TetracyclineQuinine and Tetracycline-1994-95 (All areas):S/RI = 100 %-1994-95 (All areas):S/RI = 100 %

Mefloquine monotherapy:Mefloquine monotherapy:-1991-97 (West): -1991-97 (West): S or S/RI = 80%-97%S or S/RI = 80%-97%-1992-97 (East): -1992-97 (East): S or S/RI = 100%S or S/RI = 100%

Page 3: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Monitoring in Cambodia 1998

No studyNo study Lack of budgetLack of budget Lack of human Lack of human

resourcesresources

due to Denguedue to Dengue

epidemic outbreakepidemic outbreak

Page 4: Drug Resistance Monitoring in Cambodia 1997 - 2003

S/RI68%

R32%

Mefloquine25mg

Drug Resistance of Chloroquine & Mefloquine Monotherapy 1999

Sampov Loun

Rovieng

S/RI76%

R24%

Mefloquine25mg

S/RI66%

R34%

R40%

S/RI60%

Chloroquine

Chloroquine

Mefloquine25mg/kgw

S/RI100%

R3%

S/RI97%

Mefloquine25mg/kgw

Page 5: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Artecomin Cambodia 1999

R4%

S96%

Sampov Loun

snoul

S100%

Artecom(Art.+piperaq.+trimethoprime) 2days,28days follow up

Page 6: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance of A+M in Cambodia 2000

Sampov Loun

Oral,Kg Speu

S/RI100%

S/RI100%

Page 7: Drug Resistance Monitoring in Cambodia 1997 - 2003

Samlot

Snoul

Drug Resistance of A+M Monitoring2001LTF

2%

ACPR98%

S/RI100%

Page 8: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance of Artekine 2 & Coarterm 2001

Anlong Veng

LTF7%

ACPR93%

Artekine2

42

3

LTF8%

ACPR92%

Artekine2

56

5LTF28%

ACPR72%

Coarterm

38

15

Page 9: Drug Resistance Monitoring in Cambodia 1997 - 2003

ACPR, 88%

LTF, 12%

N=82

LTF6%

ACPR94%

Drug Resistance Monitoring A+M in Cambodia 2002 LTF

3%

ACPR97%

ACPR100%

N=36

N=75

Preah Vihear

Pailin

Veal Veng

Ratanakiri

Snoul

Page 10: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance of Artekine 2 & Coarterm in Cambodia 2002

Sampov Loun

SnoulLTF27%

ACPR73%

Coarterm

N=55

ACPR100%

N=65

Artekine 2

.

Page 11: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Monitoring A+M in Cambodia 2003

Name of sites

No. of

enrollment

Drop out ACPR LTF

Oral 97

(64.7%)

06

(6.2%)

88

(96.7%)

03 a

(3.3%)

Anlong Veng

92

(61%)

02

(2.2%)

88

(97.8%)

02 b

(2.2%)

Snoul 66

(41.8%)

03

(4.5%)

63

(100%)

0

Sampov loun

55

(21%)

03

(5.5%)

48

(92.7%)

4 c

(7.3%) a = PCR confirmed all cases are recrudescing

b = Showed that both are re – infection

c = PCR confirmed all cases are recrudescing

PCR were done by Institute Pasteur of Cambodia

Page 12: Drug Resistance Monitoring in Cambodia 1997 - 2003

Drug Resistance Monitoring at sentinel sites, Cambodia 2002 & 2003

Year Name of sites No. of

enrollment

ACPR (%) LTF (%)

2002 Pailin 82 88 12

2002 Pursat 88 94 6

2002 Prah vihear 36 97 3

2002 Rattanakiri 75 100 0

2003 Battambang 55 92.7 7.7

2003 Kg. Speu 97 96.7 3.3

2003 Kratie 66 100 0

2003 O. M. Chey 92 97.8 2.2

Page 13: Drug Resistance Monitoring in Cambodia 1997 - 2003

Sentinel sites of drug resistance Sentinel sites of drug resistance monitoring in Cambodiamonitoring in Cambodia

Page 14: Drug Resistance Monitoring in Cambodia 1997 - 2003

Conclusion

The result showed the sensitivity of A+M still high (ACPR = 92 – 100%) each sentinel site if we compared to the result of previous study.

So The A+M can be continue as drug for our first line treatment of malaria.

Page 15: Drug Resistance Monitoring in Cambodia 1997 - 2003

Test systemTest systemDays 0 1 2 3 7 14 21 28 Othe

r

day

Clinical examination X X X X X X X X X

Axillary Temperature X X X X X X X X X

Treatment A+M

A=12mg/kg, for 3days

M=25mg/kg on day0

X

A+M

X

A

X

A

Parasitemia X X X X X X X X X

Blood spot (PCR)

Blood sampling

( For In Vitro test)

X

X

X X X

Page 16: Drug Resistance Monitoring in Cambodia 1997 - 2003

Thank you for your attention